Clinical Registry Platform for Oncology

Clinical Registry Platform for Oncology | CRStar

The CRStar by Health Catalyst™ application is the industry's first cloud-based cancer registry solution. You can leverage CRStar as a knowledge center of actionable insights to help guide key resource and accreditation management, planning, and cancer program growth decisions with an emphasis on quality and research. CRStar provides innovative casefinding, abstracting, data analytics, and informatics capabilities—including integrated pathology NLP automation powered by HLA Global, which accelerates and improves the accuracy of identifying reportable cancers and key clinical attributes directly within existing workflows.

CRStar empowers both individual cancer centers and large enterprise health systems to achieve their full potential by meeting and exceeding increasing regulatory, accreditation, and quality reporting requirements while also providing insights for enhancing cancer program management.

The Challenge

Rising Cancer Volume and Workforce Constraints Strain Registry Operations

Health systems that have acquired ambulatory care practices—and independent ambulatory practices alike—face tremendous financial pressures and challenges to financial sustainability. If you’re an ambulatory care leader, you’re looking to improve the efficiency of the services you provide and find cost savings without negatively impacting patient outcomes, the community, or the integrity of the organization. Yet it can be difficult to access data that brings actionable insights to inform decisions to improve patient access, panel management, provider productivity, referral management, or quality scores.

Our Approach

Cloud-Based Clinical Registry Platform with Automated Casefinding

The CRStar by Health Catalyst™ application is the industry's first cloud-based cancer registry solution. You can leverage CRStar as a knowledge center of actionable insights to help guide key resource and accreditation management, planning, and cancer program growth decisions with an emphasis on quality and research. CRStar provides innovative casefinding, abstracting, data analytics, and informatics capabilities—including integrated pathology NLP automation powered by HLA Global, which accelerates and improves the accuracy of identifying reportable cancers and key clinical attributes directly within existing workflows.

CRStar empowers both individual cancer centers and large enterprise health systems to achieve their full potential by meeting and exceeding increasing regulatory, accreditation, and quality reporting requirements while also providing insights for enhancing cancer program management.

Benefits

Real-Time Registry Dashboards, Workflow Automation, and Accreditation Support

Minimize startup time and ongoing costs. CRStar’s cloud-based, software-as-a-service design reduces IT burden and speeds implementation.
Access real-time insights through interactive dashboards. Leaders and registry teams can monitor key performance indicators such as migration patterns, market share, referral trends, productivity, incidence by site, quality measures, and more.
Strengthen abstracting and follow-up workflows. Teams can collect required or extended data sets for accreditation, research, and advanced studies, and streamline patient follow-up with automated lists and letters.
Improve casefinding accuracy with built-in automation. CRStar offers automated integration with HLA Global’s NLP Pathology solution to identify potential reportable cancer cases, streamline casefinding, and enhance consistency by reducing manual processes.

CRStar Oncology Clinical Registry Platform

CRStar is a cloud-based clinical registry platform that improves cancer data abstraction, reporting, and program performance with real-time dashboards and automation.

1. The Challenge

2. Our Approach

3. Benefits